TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Orthocell Ltd ( (AU:OCC) ) is now available.
Orthocell Ltd has announced the quotation of 230,770 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 14, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the visibility and accessibility of its securities.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on the development and commercialization of regenerative medicine products. The company specializes in innovative treatments for repairing and regenerating soft tissue injuries and musculoskeletal conditions.
Average Trading Volume: 781,534
Technical Sentiment Signal: Buy
Current Market Cap: A$297.9M
Learn more about OCC stock on TipRanks’ Stock Analysis page.